150 related articles for article (PubMed ID: 33586652)
1. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
Votquenne N; Dupire G; Michel O; Ben Said B
Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
[No Abstract] [Full Text] [Related]
2. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
Shahriari N; Strober B; Shahriari M
J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
[No Abstract] [Full Text] [Related]
3. Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.
Megna M; Genco L; Noto M; Patruno C; Fabbrocini G; Napolitano M
Dermatol Ther; 2022 Nov; 35(11):e15839. PubMed ID: 36111349
[No Abstract] [Full Text] [Related]
4. Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab.
Bai H; Murase EM; Ashbaugh AG; Botto NB; Murase JE
J Am Acad Dermatol; 2022 Sep; 87(3):692-695. PubMed ID: 35367296
[No Abstract] [Full Text] [Related]
5. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
6. Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study.
Olesen CM; Yüksel YT; Zachariae C; Lund TT; Agner T; Petersen TS; Thyssen JP
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e557-e559. PubMed ID: 36463422
[No Abstract] [Full Text] [Related]
7. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.
Loman L; Diercks GFH; Schuttelaar MLA
Contact Dermatitis; 2021 Feb; 84(2):124-127. PubMed ID: 32864776
[No Abstract] [Full Text] [Related]
8. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis.
Murphy MJ; Hwang E; Singh K; Lee T; Cohen JM; Damsky W
Br J Dermatol; 2023 Dec; 190(1):132-134. PubMed ID: 37818837
[No Abstract] [Full Text] [Related]
9. Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Lu CW; Lee WI; Chung WH
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34417287
[TBL] [Abstract][Full Text] [Related]
10. A review of dupilumab in the treatment of atopic diseases.
Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
[TBL] [Abstract][Full Text] [Related]
11. Eczematous reaction to ixekizumab successfully treated with dupilumab.
Napolitano M; Gallo L; Patruno C; Fabbrocini G; Megna M
Dermatol Ther; 2020 Mar; 33(2):e13218. PubMed ID: 31912951
[No Abstract] [Full Text] [Related]
12. Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
Choi S; Zhu GA; Lewis MA; Honari G; Chiou AS; Ko J; Chen JK
J Am Acad Dermatol; 2020 May; 82(5):1252-1255. PubMed ID: 31923445
[No Abstract] [Full Text] [Related]
13. A case of eczematous eruption occurring during treatment with risankizumab.
DE Luca E; Caldarola G; DI Stefani A; D'Amore A; Sfregola S; DE Simone C
Ital J Dermatol Venerol; 2023 Feb; 158(1):64-65. PubMed ID: 36939506
[No Abstract] [Full Text] [Related]
14. Dupilumab as a novel therapy to treat adrenergic urticaria.
Goodman B; Jariwala S
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):205-206. PubMed ID: 32621993
[No Abstract] [Full Text] [Related]
15. Granulomatous skin lesions of common variable immunodeficiency treated with sirolimus.
Lee AY; Huynh N; Lin MW
Australas J Dermatol; 2021 Aug; 62(3):434-435. PubMed ID: 33660846
[No Abstract] [Full Text] [Related]
16. Promising results for treatment of severe chronic hand eczema with dupilumab.
Brans R
Br J Dermatol; 2023 Sep; 189(4):360-361. PubMed ID: 37337439
[No Abstract] [Full Text] [Related]
17. Immunotherapy-induced eczema treated with dupilumab.
D'Erme AM; Fidanzi C; Mori N; Musettini G; Cupini S; Barbara C; Allegrini G; Bagnoni G; Janowska A
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e447-e449. PubMed ID: 38084780
[No Abstract] [Full Text] [Related]
18. Strategies for Successful Management of Severe Atopic Dermatitis.
Brar KK; Nicol NH; Boguniewicz M
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
20. Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation.
Boland BS; Riedl MA; Valasek MA; Crowe SE; Sandborn WJ
Am J Gastroenterol; 2017 Oct; 112(10):1621. PubMed ID: 28978958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
